Global Cancer Biopsy Industry Poised for Explosive Growth at 18% CAGR, Reaching US$131.4 Billion by 2033 | FMI Analysis

The Global Cancer Biopsy Industry is on track for a remarkable surge, fueled by advancements in cancer diagnosis. According to a new report by Future Market Insights (FMI), the market reached an estimated value of US$22.2 billion in 2022 and is projected to soar at a staggering Compound Annual Growth Rate (CAGR) of 18% from …

Cancer Biopsy Market’s Soaring Trajectory: US$ 131.4 Billion Forecasted by 2033, CAGR of 18% | Revealed by FMI

In a recently published analysis report, Future Market Insights reveals that the global Cancer Biopsy Market achieved remarkable sales of US$ 22.2 Billion in 2022. Anticipating an impressive 18% Compound Annual Growth Rate (CAGR), the market’s projected growth from 2023 to 2033 is set to surpass historical trends. Notably, the Tissue Biopsies segment is forecasted …

Bridging the Diagnostic Frontier: Cancer Biopsy Market’s 18% CAGR Journey to US$131.4 Billion From 2023 To 2033

The Cancer Biopsy Market revenues were estimated at US$ 22.2 Bn in 2022 and are anticipated to grow at a CAGR of 18% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 131.4 Bn. The increasing elderly populace, along with the rise in instances of cancer diagnoses, …